SCHEMBL23794112

SCHEMBL23794112

CC(C)(F)CN1CCc2c([nH]c3ccccc23)C1c1c(F)cc(OC2CN(CCCF)C2)cc1F

nearest known ligand 0.74

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 20/20 0.74
▸ CYP3A4 P08684 1/20 0.49
▸ KCNH2 Q12809 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17858935 0.94 ESR1 (0.67) ESR1CYP3A4KCNH2
SCHEMBL17858907 0.93 ESR1 (0.66) ESR1CYP3A4KCNH2
SCHEMBL21012130 0.92 ESR1 (0.73) ESR1
SCHEMBL23793738 0.92 ESR1 (0.73) ESR1
SCHEMBL22213732 0.90 ESR1 (0.60) ESR1CYP3A4KCNH2
SCHEMBL22881884 0.90 ESR1 (0.62) ESR1
SCHEMBL24027047 0.89 ESR1 (0.59) ESR1
SCHEMBL24027012 0.88 ESR1 (0.60) ESR1
SCHEMBL31280249 0.87 ESR1 (0.57) ESR1CYP3A4KCNH2
SCHEMBL17858901 0.87 ESR1 (0.62) ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023091550-A1 METHODS OF TREATING ESTROGEN RECEPTOR-ASSOCIATED DISEASES OLEMA PHARMACEUTICALS, INC. (US) 2023-05-25 — — WO disclosed
WO-2021178846-A1 METHODS OF TREATING ESTROGEN RECEPTOR-ASSOCIATED DISEASES OLEMA PHARMACEUTICALS, INC. (US) 2021-09-10 — — WO disclosed
Send feedback